Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancer

A Elhammali, P Blanchard, A Yoder, Z Liao… - Radiotherapy and …, 2019 - Elsevier
Background & purpose We report disease control, survival, and toxicity in patients with
advanced inoperable non-small cell lung cancer (NSCLC) receiving concurrent chemotherapy …

PSA: Declining utilization of prostate brachytherapy

L Andring, A Yoder, T Pezzi, C Tang, R Kumar… - Brachytherapy, 2022 - Elsevier
PURPOSE To analyze rates of brachytherapy use for prostate cancer over time and evaluate
patient characteristics, demographics and factors predictive for its utilization. METHODS …

Impact of treatment modality on pelvic floor dysfunction among uterine cancer survivors

DS Lakomy, AK Yoder, J Wu, M Hernandez… - International Journal of …, 2022 - ijgc.bmj.com
Objective Pelvic floor dysfunction is a common adverse effect of uterine cancer treatment. In
this study we compared patient-reported outcomes regarding pelvic floor dysfunction among …

SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection

AS Farooqi, AK Yoder, HY Lin, D Pasalic… - International Journal of …, 2024 - Elsevier
Purpose The lungs are the most common site of metastasis for patients with soft tissue
sarcoma. SABR is commonly employed to treat lung metastases among select patients with …

Long-term survival following definitive radiation therapy for recurrence or oligometastases in gynecological malignancies: A landmark analysis

KL Corrigan, A Yoder, B De, L Lin, A Jhingran… - Gynecologic …, 2022 - Elsevier
Objective Radiation therapy (RT) may improve outcomes for patients with oligometastatic
cancer. We sought to determine if there are long-term survivors treated with definitive RT for …

[HTML][HTML] New paradigm for radiation in multiple myeloma: lower yet effective dose to avoid radiation toxicity

…, SA Milgrom, CC Pinnix, T Andraos, A Yoder… - …, 2020 - ncbi.nlm.nih.gov
Plasmacytomas are local tumor deposits of multiple myeloma (MM) that can cause focal
symptoms including nerve compression, pain, and fracture. Although systemic therapy is the …

Definitive local therapy for T4 prostate cancer associated with improved local control and survival

…, I Abu‐Gheida, T Bathala, AK Yoder… - BJU …, 2023 - Wiley Online Library
Objectives To evaluate patients with clinical (c)T4 prostate cancer (PCa), which represent
both a heterogenous and understudied population, who often present with locally advanced …

Effect of quality of life on radiation adherence for patients with cervical cancer in an urban safety net health system

AK Yoder, E Dong, X Yu, A Echeverria… - International Journal of …, 2023 - Elsevier
Purpose Outcomes for patients undergoing chemoradiation for cervical cancer are
dependent on adherence to radiation therapy (RT). In other diseases, quality of life (QoL) is …

Outcomes after definitive treatment for cutaneous angiosarcomas of the face and scalp: Reevaluating the role of surgery and radiation therapy

AK Yoder, AS Farooqi, C Wernz, A Subramaniam… - Head & …, 2023 - Wiley Online Library
Introduction We investigated outcomes and prognostic factors for patients treated for cutaneous
angiosarcoma (CA). Methods We conducted a retrospective review of patients treated for …

Postoperative radiotherapy for multiple myeloma of long bones: should the entire rod be treated?

…, SA Milgrom, B Amini, JR Gunther, A Yoder… - … Myeloma and Leukemia, 2019 - Elsevier
Purpose To characterize local relapse after surgical fixation and postoperative radiotherapy
(RT) for multiple myeloma (MM) with cortical involvement of long bones. Patients and …